On Wednesday 25 November, the European Commission is due to present its pharmaceutical strategy, which aims to “ensure accessibility, sustainability and security of supply” in Europe (see EUROPE B12498A4). According to a draft text unveiled by Reuters, the communication could introduce several new measures by 2022.
“The Commission will consider targeted policies that support greater generic and biosimilar competition”, the news agency said. According to Reuters the proposal will...